CT TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PLANNING APPLICATION— 510(k) K132524

Substantially Equivalent

Philips Medical Systems

FDA 510(k) clearance K132524 for CT TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) PLANNING APPLICATION, Substantially Equivalent on 2014-06-13. Applicant: Philips Medical Systems.

Clearance details

Applicant: Philips Medical Systems
Product code: Code JAK
Advisory panel: Radiology
Date received: 2013-08-12
Decision date: 2014-06-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cleveland, OH, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JAK

product code JAK

Death: 27
Injury: 571
Malfunction: 779
Total: 1,377

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.